Biography
Dr. Verma is a clinician-investigator interested in chronic kidney disease (CKD), renal amyloidosis, cardiorenal syndrome, diabetic kidney disease (DKD), renal physiology, and electrolyte abnormalities. Dr. Verma's research projects include epidemiologic investigations utilizing large databases and translational and patient-oriented research projects. Ongoing studies include predictors of CKD progression using CRIC cohort and UK biobank, predictors of mortality using NHANES, a Physiology study examining the role of Kidney Function Reserve and renal plasma flow in phenotyping chronic kidney disease, and the role of intravitreal VEGF inhibitors in causing nephrotoxicity, and renal physiology of decongestion in patients with Acute decompensated heart failure(ADHF). Dr. Verma is a member of the APRC committee for the Framingham Heart Study, the Renal subgroup for clinical endpoints in Amyloidosis for the Amyloidosis research consortium, and the Membership Committee for Kidney in Cardiovascular Medicine for the American Heart Association. He is on the Editorial Board of Therapeutic Advances in Endocrinology and Metabolism, Therapeutic Advances in Chronic Disease, Plos One, and BMC Medicine.